Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) EV/Sales
As of 16 October 2026, Veeva Systems Inc. (VEEV) trades at a EV/Sales of 12.5×. Over the past ten years it has ranged from 5.3× (June 2026) to 35.0× (October 2020); the current reading is higher than 51% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 8.4× | (29.57%) |
| FY2025 | 11.9× | (4.12%) |
| FY2024 | 12.4× | 14.05% |
| FY2023 | 10.9× | (40.68%) |
| FY2022 | 18.3× | (34.54%) |
| FY2021 | 28.0× | 49.98% |
| FY2020 | 18.6× | 9.78% |
| FY2019 | 17.0× | 45.52% |
| FY2018 | 11.7× | 22.94% |
| FY2017 | 9.5× | 35.40% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jul 2026 | 7.5× | 36.54% |
| Apr 2026 | 5.5× | (34.56%) |
| Jan 2026 | 8.4× | (37.38%) |
| Oct 2025 | 13.4× | (1.06%) |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 1.0× |
| WAY Waystar Holding Corp. compare | 5.4× |
| HQY HealthEquity, Inc. compare | 6.1× |
| DOCS Doximity, Inc. compare | 7.6× |
| TEM Tempus AI, Inc. compare | 8.5× |
| HNGE Hinge Health Inc. compare | 10.3× |
| VEEV Veeva Systems Inc. | 12.5× |
| TXG 10x Genomics compare | 13.9× |
| HTFL Heartflow, Inc. compare | 19.8× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement